Rhinegene Germany
RhineGene Germany GmbH is the Munich-based German subsidiary of RhineGene B.V. that distributes molecular diagnostic products, including more than 350 Real-Time PCR kits and automated nucleic acid extraction and Real-Time PCR instruments, to clinical laboratories, hospitals, research institutions, and food safety buyers across EMEA via direct field sales.
- Company typePrivate
- Founded2010
- HeadquartersMunich, Germany
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Rhinegene Germany does
RhineGene Germany GmbH (Leopoldstrasse 244, 80807 Munich) is the German operating subsidiary of RhineGene B.V., a Netherlands-incorporated holding entity established in 2022 that sits within the Turkey-headquartered Anatolia Geneworks group. The company develops, markets, and distributes molecular diagnostic products, anchored by a portfolio of more than 350 Real-Time PCR kits spanning infectious disease detection (sepsis, hepatitis, respiratory pathogens, STDs, HPV, tropical pathogens), genetic disorder screening (thrombophilia, FMF, HLA-B, IL28B, SMA), food safety testing (GMO screening, species identification, food pathogen detection), and drug-resistance sequencing for HBV, HCV, and HIV-1. Its instrument portfolio comprises automated nucleic acid extraction systems (UNIO B48, UNIO B24, UNIO 96, UNIO M32, UNIO A24S, Magnesia 2448), manual magnetic-bead stands (Magrev 24, Magrev Mini), and the Montania 4896 dual-block Real-Time PCR detection platform, all built around silica-coated magnetic bead extraction chemistry with IVD-CE regulatory marking.
RhineGene Germany operates an enterprise field-sales go-to-market, employing Product Specialists who visit clinical laboratories, hospital diagnostic departments, research centres, and universities across Germany for product demonstration, training, and ongoing customer support. Commercial activity is layered with participation in major European industry events such as MEDICA and ECCMID, often jointly with parent Anatolia Geneworks, and reinforced by an active LinkedIn and Instagram presence. Pricing is not publicly disclosed and is handled through direct contact with local representatives. Regional subsidiaries in Poland (Łódź) and Bulgaria (Sofia Tech Park) extend the group's footprint in EMEA, while a Philippines entity supports APAC distribution; Germany, Poland, and Bulgaria are staffed with local phone lines and country-specific email addresses for customer engagement.
Revenue mechanics combine one-time kit sales (consumables sold in 25-, 50-, 100-, or 96-reaction formats) with instrument placement and downstream reagent pull-through, generating a classic razor-razorblade dynamic tied to the installed base of UNIO extraction systems and Montania PCR instruments. The company serves a vertically segmented base of healthcare laboratories, hospital diagnostics, academic and biomedical research institutions, and food safety/quality assurance buyers, without disclosed named anchor customers, public revenue, or external funding rounds. Headcount at the German subsidiary is reported in the 1-10 range, consistent with a lean regional sales-and-support operation backed by the broader Anatolia Geneworks R&D and manufacturing infrastructure.
Rhinegene Germany firmographics
Firmographics- Name
- Rhinegene Germany
- Legal name
- RhineGene Germany GmbH
- Website
- https://rhinegene.de
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- RhineGene Germany GmbH is the Munich-based German subsidiary of RhineGene B.V. that distributes molecular diagnostic products, including more than 350 Real-Time PCR kits and automated nucleic acid extraction and Real-Time PCR instruments, to clinical laboratories, hospitals, research institutions, and food safety buyers across EMEA via direct field sales.
- Ownership category
- akta.pro rank
Rhinegene Germany industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
- akta.pro secondary industries
- Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices) (AFALAEAK), Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA), Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC)
Keywords
Where Rhinegene Germany is headquartered
LocationHeadquarters
- HQ city
- Munich
- HQ country
- Germany
- HQ region
- Europe
Offices4 records
Markets served
Rhinegene Germany business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Molecular Diagnostics Kits Sales: Sale of diagnostic kits including Real-Time PCR kits for pathogen detection, hepatitis, respiratory pathogens, STDs, genetic disorders, food safety testing, and sequencing. Revenue is generated through one-time purchase of kits, which are consumed in laboratory testing. Products available in multiple reaction sizes (25, 50, 100, 96 reactions).
- Instrument Sales and Service: Sale and distribution of automated nucleic acid extraction instruments (UNIO B48, UNIO B24, UNIO 96, UNIO M32, UNIO A24S, Magnesia 2448) and Real-Time PCR systems (Montania 4896). May include service and support contracts.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Rhinegene Germany product offering
Product offeringCore offering
RhineGene Germany develops and supplies molecular diagnostic kits and instruments used by clinical and research laboratories. Its portfolio includes more than 350 Real-Time PCR kits covering pathogen detection, hepatitis, respiratory infections, STDs, genetic disorder screening, food safety testing, and sequencing, together with automated and manual nucleic acid extraction instruments (UNIO series, Magnesia, Magrev) and the Montania 4896 real-time PCR detection system.
Product overview
RhineGene is a molecular diagnostics company offering a comprehensive portfolio of diagnostic solutions comprising laboratory instruments and consumable kits. The product ecosystem centers on automated and manual nucleic acid extraction instruments (Unio B48, B24, 96, A24S, M32, Magrev 24/Mini, Magnesia 2448) paired with over 350 Real-Time PCR kits for detection, quantitation, and genotyping applications. Key kit categories include microbiology panels (Sepsis, Respiratory, Hepatitis, HPV, STDs, Herpes, Tropical pathogens), genetic disorder screening (Thrombophilia, FMF, HLA-B, IL28B, SMA), food safety testing (GMO, species identification, pathogen detection), and sequencing kits for drug resistance testing. The instruments and kits work as an integrated workflow: samples are extracted using Unio/Magnesia/Magrev systems, then analyzed on the Montania 4896 real-time PCR platform or sent for sequencing, with specialized panel kits enabling multiplex syndromic testing across clinical applications.
Differentiator
Problem solved
Functional benefit
Brands
- Bosphore: Brand for PCR detection kits including microbiology, hepatitis, HPV, and other diagnostic tests
- Montania
- Magrev
- Unio
- Magnesia
Products and services
- UNIO B48 Automated nucleic acid extraction instrument with two independent 24-sample blocks enabling simultaneous extraction. Designed for clinical and research laboratories performing DNA/RNA extraction from varied sample types using magnetic bead technology; rapid extraction in as quick as 18 minutes.
- UNIO B24 Automated nucleic acid extraction system for DNA and RNA from various sample types including blood, serum, and plasma using paramagnetic particle technology; for clinical and research laboratory use.
- UNIO 96 Fully automated high-throughput system for 96 samples combining nucleic acid extraction and PCR setup, with integrated UV decontamination, barcode readers, and rapid methods supporting 30 to 90-minute runs.
- Montania 4896 Real-time PCR detection system with two 48-well blocks enabling simultaneous execution of two independent protocols; features fiber optic detection, PMT module photon energy amplification, automated configuration, optional barcode reader, and four filter pairs (470/510, 530/565, 580/620, 630/665 nm) for multiplex detection across FAM/SYBR Green, VIC/HEX/JOE/TET/TAMRA, ROX/Texas Red, and Cy5 dyes. IVD-CE marked.
- UNIO A24S Fully automated DNA/RNA extraction and PCR setup instrument using silica-coated magnetic bead technology with ready-to-use cartridges, liquid level detection sensor, cooling/heating module, UV lamps for contamination reduction, automatic tip loading/disposal, and barcode reader for full traceability. Processes 1–24 samples simultaneously with multiple thermic protocols. IVD-CE marked.
- Magnesia 2448 Automated extraction and PCR setup system using silica-coated magnetic bead technology to process 1–48 samples simultaneously for DNA/RNA extraction and downstream PCR plate preparation.
- UNIO M32 Automated nucleic acid extraction system for DNA and RNA from biological samples using silica-coated magnetic beads with ready-to-use pre-filled kits. IVD-CE marked.
- Magrev 24 Manual nucleic acid extraction stand using silica-coated magnetic beads for 24 samples, enabling processing, washing, separation, and elution steps without centrifugation. IVD-CE marked.
- Magrev Mini Compact manual magnetic bead nucleic acid extraction stand with 2 slots for flexible sample processing based on current laboratory needs. IVD-CE marked.
- Real-Time PCR Kits (350+ catalog) Portfolio of more than 350 Real-Time PCR kits for detection, quantitation, and genotyping of pathogens, genetic disorder identification and screening, and food safety parameters. Available in multiple reaction sizes (25, 50, 100, 96 reactions).
- Sepsis Panel Kit Multiplex panel kit for detection of sepsis pathogens from blood cultures, covering bacteria, fungi, and antibiotic resistance genes in a single assay.
- Hepatitis Kits Quantitative and qualitative detection kits for HBV and HCV, including genotyping and ultra-sensitive quantification kits.
- Respiratory Pathogens Kits Panel and detection kits for respiratory pathogens including influenza, RSV, coronaviruses, bocavirus, and bacterial pneumonia panels.
- Nucleic Acid Extraction Kits State-of-the-art kits for nucleic acid isolation including manual magnetic bead, spin column, direct extraction, and automated extraction options for laboratory use.
- Multiplex Panel Kits Comprehensive testing kits enabling simultaneous detection of multiple targets in a single assay, with panels for STD, Respiratory, CNS, Meningitis, Rash, Viral Infections in Immunosuppressed Patients (VIP), Sepsis, and Gastroenteritis.
- Genetic Disorder Kits Genetic screening kits for thrombophilia, familial Mediterranean fever (FMF), HLA-B typing, interleukin-28B detection, and spinal muscular atrophy (SMA).
- Food Testing Kits Comprehensive food safety testing kits covering plant species detection, GMO screening and event detection/quantification, meat and dairy species identification, and food pathogen detection for food manufacturers and regulatory bodies.
- Sequencing Kits Drug resistance mutation sequencing kits for HBV, HCV, and HIV-1 covering various genomic regions for treatment monitoring.
Quantifiable outcome
- More than 350 Real-Time PCR kits available for diverse diagnostic applications
- +2 more outcomes
Companies that use Rhinegene Germany
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
Rhinegene Germany technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Rhinegene Germany partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Anatolia Tanı ve Biyoteknoloji Ürünleri Ar-Ge San. ve Tic. A.Ş. (Anatolia Geneworks)coreAnatolia Geneworks is the parent company of RhineGene. RhineGene is a subsidiary of RhineGene B.V. Netherlands, which is part of the Anatolia Geneworks group. Personal data is shared with HQ (Anatolia Tanı ve Biyoteknoloji Ürünleri Ar-GE SAN. VE TİC. A.Ş.) for management reporting purposes. RhineGene participates in trade shows and events jointly with Anatolia Geneworks (MEDICA, ECCMID).
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Rhinegene Germany competitors and assessment
Company assessmentBroad incumbents
- Cepheid (Danaher): Developer of the GeneXpert molecular diagnostics platform, dominant in syndromic and infectious disease PCR testing. Competes with RhineGene in clinical microbiology and represents the kind of closed-system incumbent whose installed-base stickiness RhineGene must overcome.
- BioMérieux: Global leader in microbiology and molecular diagnostics (BioFire, ARGENE, etc.) with extensive PCR kit and instrument offerings. Overlaps with RhineGene across infectious disease and food pathogen testing, but operates at vastly larger scale and broader portfolio.
- Hologic: Major molecular diagnostics player with the Panther system and broad infectious disease and women's health menu. Comparable to RhineGene in clinical molecular diagnostics, with significantly larger scale and installed base.
- Roche Diagnostics: World-leading IVD player with the cobas and LightCycler PCR systems and broad infectious disease and HPV menu. Competes with RhineGene in clinical molecular diagnostics and represents the dominant incumbent that labs typically benchmark against.
- Qiagen: Germany-headquartered global leader in sample preparation (QIAcube), PCR kits (QuantiNova, QIAstat-Dx), and molecular testing consumables. Direct overlap with RhineGene's sample-prep (UNIO) and PCR kit (Bosphore) categories, with much larger installed base and brand.
- Abbott Diagnostics: Global IVD major with the m2000 Real-Time PCR system and Alinity m molecular diagnostics platform. Overlaps with RhineGene on infectious disease and STI molecular testing, with much greater clinical lab share.
Emerging players
- Genetic Signatures: Smaller specialty molecular diagnostics firm focused on syndromic infectious disease detection. Comparable to RhineGene as a smaller, single-platform specialist with sales effort concentrated in select markets rather than global scale.
Direct peers
- Certest Biotec: Spanish molecular diagnostics firm offering Real-Time PCR kits and IVD-CE marked reagents across infectious disease, food safety, and veterinary testing. Comparable mid-sized European peer with similar product portfolio breadth and IVD-CE positioning.
- ELITech Group: European-headquartered molecular diagnostics and sample-prep specialist offering Real-Time PCR kits (infectious disease, microbiology) and automated extraction instruments. Closely comparable to RhineGene on product mix, customer base (clinical and food labs), and geographic footprint in Continental Europe.
- TIB Molbiol: Berlin-based developer of Real-Time PCR kits for infectious disease and genetic testing, with strong European clinical lab presence. Highly comparable on kit breadth, target customer (clinical labs), and emergence from a mid-sized European specialty diagnostics base.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Rhinegene Germany social profiles
Digital presenceRhinegene Germany compliance and trust
Trust signalCompliance1 record
Rhinegene Germany financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rhinegene Germany leadership team
Management profileNumber of profiles
Profiles1 record
Rhinegene Germany subsidiaries and ownership
Company hierarchySubsidiaries3 records
Rhinegene Germany funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rhinegene Germany M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rhinegene Germany
What does Rhinegene Germany do?
RhineGene Germany develops and supplies molecular diagnostic kits and instruments used by clinical and research laboratories. Its portfolio includes more than 350 Real-Time PCR kits covering pathogen detection, hepatitis, respiratory infections, STDs, genetic disorder screening, food safety testing, and sequencing, together with automated and manual nucleic acid extraction instruments (UNIO series, Magnesia, Magrev) and the Montania 4896 real-time PCR detection system.
Is Rhinegene Germany a public or private company?
Rhinegene Germany is a private company. It is classified as corporate owned and is currently operating.
When was Rhinegene Germany founded?
Rhinegene Germany was founded in 2010. It employs 1 to 10 people.
Where is Rhinegene Germany based?
Rhinegene Germany is headquartered in Munich, Germany, in the Europe region.
How does Rhinegene Germany make money?
Two revenue lines are on record. Molecular Diagnostics Kits Sales are the primary driver. The others are instrument Sales and Service.
Who are Rhinegene Germany's main competitors?
Broad incumbents on record are Cepheid (Danaher), BioMérieux, Hologic, Roche Diagnostics, Qiagen and Abbott Diagnostics. Genetic Signatures is listed as an emerging player. Direct peers are Certest Biotec, ELITech Group and TIB Molbiol.
Does Rhinegene Germany have an API?
No public API is recorded for Rhinegene Germany.
What industry is Rhinegene Germany in?
Rhinegene Germany's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of AFALAEAK, Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices). Its NAICS code is 325413 and its SIC code is 2835.